Eli Lilly and Company (LLY) — Financial statements
Income statement, balance sheet, and cash flow for Eli Lilly and Company — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 65,179↑44.7% | 45,043↑32.0% | 34,124↑19.6% | 28,541↑0.8% | 28,318 | |
| Cost of Revenue | 10,564↑25.5% | 8,418↑18.9% | 7,082↑6.8% | 6,630↓9.3% | 7,313 | |
| Gross Profit | 54,615↑49.1% | 36,624↑35.4% | 27,042↑23.4% | 21,912↑4.3% | 21,006 | |
| Operating Expenses | ||||||
| R&D Expenses | 13,338↑21.4% | 10,991↑18.0% | 9,313↑29.5% | 7,191↑3.8% | 6,931 | |
| General & Administrative Expenses | 11,094↑36.4% | 8,132↑17.2% | 6,941↑14.4% | 6,068↓1.2% | 6,142 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 11,094↑36.4% | 8,132↑17.2% | 6,941↑14.4% | 6,068↓1.2% | 6,142 | |
| Other Expenses | 488 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 24,919↑30.3% | 19,123↑17.6% | 16,255↑22.6% | 13,258↑1.4% | 13,073 | |
| Total Costs & Expenses | 35,483↑28.8% | 27,541↑18.0% | 23,337↑17.3% | 19,888↓2.4% | 20,385 | |
| Operating Results | ||||||
| Operating Income | 29,696↑69.7% | 17,502↑62.2% | 10,787↑24.7% | 8,653↑9.1% | 7,933 | |
| Depreciation & Amortization | 1,564↓11.5% | 1,767↑15.7% | 1,527↑0.3% | 1,523↓1.6% | 1,548 | |
| EBITDA | 27,937↑83.5% | 15,228↑77.7% | 8,568↓1.1% | 8,661↑7.7% | 8,043 | |
| EBIT | 26,373↑95.9% | 13,461↑91.2% | 7,041↓1.4% | 7,138↑9.9% | 6,495 | |
| Interest & Other Income | ||||||
| Net Interest Income | -642↓6.0% | -605↓93.9% | -312↓16.2% | -269↑14.5% | -314 | |
| Interest Income | 153↓12.5% | 175↑0.9% | 174↑176.4% | 63↑147.2% | 25 | |
| Interest Expense | 795↑1.9% | 781↑60.7% | 486↑46.5% | 332↓2.4% | 340 | |
| Non-Operating Income | 3,323↓17.8% | 4,041↑7.8% | 3,747↑147.3% | 1,515↑5.4% | 1,438 | |
| Other Income / Expenses | -3,965↑17.8% | -4,821↓13.9% | -4,233↓129.2% | -1,847↓3.9% | -1,778 | |
| Income Before Tax | 25,730↑102.9% | 12,680↑93.5% | 6,555↓3.7% | 6,806↑10.6% | 6,156 | |
| Income Tax Expense | 5,092↑143.6% | 2,090↑59.1% | 1,314↑134.0% | 562↓2.1% | 574 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 20,638↑94.9% | 10,590↑102.1% | 5,240↓16.1% | 6,245↑11.9% | 5,582 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 20,638↑94.9% | 10,590↑102.1% | 5,240↓16.1% | 6,245↑11.9% | 5,582 | |
| Bottom-Line Net Income | 20,638↑94.9% | 10,590↑102.1% | 5,240↓16.1% | 6,245↑11.9% | 5,582 | |
| EPS (Basic) | 23.00↑95.6% | 11.76↑101.7% | 5.83↓11.3% | 6.57↑12.3% | 5.85 | |
| EPS (Diluted) | 22.95↑96.0% | 11.71↑101.9% | 5.80↓11.7% | 6.57↑12.3% | 5.85 | |
| Weighted Average Shares | 898↓0.3% | 901↑0.1% | 899↓5.3% | 950↓0.4% | 954 | |
| Weighted Average Diluted Shares | 898↓0.7% | 904↑0.1% | 903↓4.9% | 950↓0.4% | 954 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.